Position in VRTX
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$503,684
+$50,446 QoQ
Shares Held
1,014
-0.1% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
#1,073
of 1,735 holders
Holding Since
Jun 2021
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 202617 CAPITAL PARTNERS, LLC holds $838,524 across 2 Biotechnology names. VRTX ranks #1 (60.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,014 | $503,684 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
537 | $334,840 |
All Filings in VRTX
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $503,684 | 1,014 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $453,238 | 1,015 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $448,826 | 990 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $387,723 | 990 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $454,104 | 1,020 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $484,820 | 1,000 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $400,686 | 995 | Shares | Sole | 2025-01-28 | |
| 2024-09-30 | $461,359 | 992 | Shares | Sole | 2024-11-01 | |
| 2024-06-30 | $464,032 | 990 | Shares | Sole | 2024-07-18 | |
| 2024-03-31 | $392,929 | 940 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $783,263 | 1,925 | Shares | Sole | 2024-01-11 | |
| 2022-09-30 | $431,414 | 1,490 | Shares | Sole | 2022-11-21 | |
| 2022-06-30 | $419,867 | 1,490 | Shares | Sole | 2022-07-08 | |
| 2022-03-31 | $388,845 | 1,490 | Shares | Sole | 2022-04-20 | |
| 2021-12-31 | $250,344 | 1,140 | Shares | Sole | 2022-01-14 | |
| 2021-06-30 | $332,891 | 1,651 | Shares | Sole | 2021-08-06 | |
| No filing history on record for this holder in this stock. | ||||||